2016 Mortgage Daily Mortgage Employment Index Up
Apr 10, 2017 11:02 am UTC| Business
DALLAS, April 10, 2017 -- During all of last year, staffing in the mortgage industry expanded -- though rising interest rates are likely to reverse recent gains. California experienced the biggest quarterly gain. As...
2016 Mortgage Daily Mortgage Employment Index Up
Apr 10, 2017 11:02 am UTC| Business
DALLAS, April 10, 2017 -- During all of last year, staffing in the mortgage industry expanded -- though rising interest rates are likely to reverse recent gains. California experienced the biggest quarterly gain. As...
DSP Group Inc.’s First Quarter 2017 Earnings Release and Conference Call
Apr 10, 2017 11:02 am UTC| Business
LOS ALTOS, Calif., April 10, 2017 -- DSP Group® Inc. (NASDAQ:DSPG), will release its earnings results for the first quarter of 2017 on April 27th, 2017 before market opens. The company would like to invite you to...
DSP Group Inc.’s First Quarter 2017 Earnings Release and Conference Call
Apr 10, 2017 11:02 am UTC| Business
LOS ALTOS, Calif., April 10, 2017 -- DSP Group® Inc. (NASDAQ:DSPG), will release its earnings results for the first quarter of 2017 on April 27th, 2017 before market opens. The company would like to invite you to...
DSP Group Inc.’s First Quarter 2017 Earnings Release and Conference Call
Apr 10, 2017 11:02 am UTC| Business
LOS ALTOS, Calif., April 10, 2017 -- DSP Group® Inc. (NASDAQ:DSPG), will release its earnings results for the first quarter of 2017 on April 27th, 2017 before market opens. The company would like to invite you to...
NeuroDerm to Host Investor Day on April 21, 2017
Apr 10, 2017 11:01 am UTC| Business
REHOVOT, Israel, April 10, 2017 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced that the Company...
NeuroDerm to Host Investor Day on April 21, 2017
Apr 10, 2017 11:01 am UTC| Business
REHOVOT, Israel, April 10, 2017 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced that the Company...